학술논문
The CELLO trial: Protocol of a planned phase 4 study to assess the efficacy of Ocrelizumab in patients with radiologically isolated syndrome
Document Type
Article
Author
Source
In Multiple Sclerosis and Related Disorders December 2022 68
Subject
Language
ISSN
2211-0348